He also noted that preclinical studies of the drug have been completed.
“A letter has been sent to the Ministry of Health requesting permission for the first phase of testing. As soon as the department approves the research, the recruitment of volunteers will begin,” Kaprin said.
According to him, vaccination will be contraindicated in patients with incomplete chemotherapy during the treatment period.
Earlier, the director of the National Research Center for Epidemiology and Microbiology (SRC) named after Gamaleya, Alexander Gintsburg, announced clinical trials of a cancer vaccine in the fall of 2025.
“At best, they will start in the middle of next year,” he said.
